Key Highlights

  • BrainChip ended the June 2026 quarter with A$20.3 million in cash, according to its quarterly activities report.
  • The company received its first production batch of 2,000 AKD1500 neuromorphic processors during the quarter.
  • The planned AKD1500 production run was revised to approximately 60,000 units because of lower-than-expected production yields.
  • BrainChip's LDA Capital Put Option agreement expired, with remaining Collateral shares expected to be liquidated following settlement of the associated obligation.

BrainChip Holdings (ASX:BRN) was lower in morning trading on 14 August 2026, placing the stock under renewed attention as investors assess the company's progress toward commercialising its neuromorphic artificial intelligence technology. The company's 27 July quarterly activities report outlined developments across AKD1500 production, intellectual-property licensing, customer engagement, product development and its financial position.

The update also provided details on the company's transition from development activity toward broader commercial deployment. BrainChip said it had received its first production batch of AKD1500 processors and was preparing additional hardware platforms intended to make the technology more accessible to customers and development partners.

AKD1500 Moves Into Production

A central development during the June quarter was the receipt of 2,000 production AKD1500 chips. BrainChip said the first batch marked a transition from pre-production evaluation devices to commercial-scale manufacturing.

The company expects additional units to be delivered during the third quarter, with the total production run now expected to be approximately 60,000 units. This is below the quantity originally anticipated because production yields were lower than expected. BrainChip said it was reviewing production data to determine the reason for the variance.

The company plans to allocate more than 2,000 AKD1500 devices to hardware enablement during the second half of 2026. Planned formats include M.2 accelerator modules, PCIe accelerator cards and Raspberry Pi development boards, alongside application-focused reference platforms for areas including radar and electronic warfare.

Licensing and Ecosystem Development

BrainChip also reported progress in its intellectual-property licensing activities. During the quarter, RTL design Assets were delivered to EDGEAI under an existing Akida 2.0 licensing agreement. The delivery allows EDGEAI to integrate BrainChip's technology into future custom silicon applications.

The company also entered an IP licensing agreement with ASICLAND during May and expanded its ecosystem through software and hardware partnerships. In June, BrainChip announced a strategic Partnership with MicroIP aimed at integrating its neuromorphic technology with hardware and software capabilities for edge AI applications.

These developments form part of BrainChip's stated strategy of pursuing commercial opportunities through silicon sales, licensing arrangements and potential royalty-generating agreements.

Cash Position and Financing Arrangement

BrainChip reported an ending cash balance of A$20.3 million for the June quarter. Its financial update also referenced net operating cash outflows of US$4.7 million, compared with US$5.3 million in the preceding quarter. Customer-related cash inflows were US$0.15 million, while payments to suppliers and employees totalled US$5.1 million.

Separately, the company's put option agreement with LDA Capital expired on 30 June 2026. A contractual A$1.0 million failure fee was settled through the sale of approximately 6.96 million BrainChip shares held as collateral. Around 6.0 million collateral shares remained with LDA at the time of the report, with the company expecting proceeds from their eventual disposal after applicable fees and amounts payable under the arrangement.

Development Pipeline Extends Beyond AKD1500

BrainChip said development of the AKD2500 remained on schedule for an early December tapeout. Its generative AI program was also progressing, with internal demonstrations expected during the latter part of the third quarter of calendar 2026.

The company is simultaneously developing four AI models focused on radar and electronic warfare applications, covering areas such as signal classification, threat detection, object identification and spectrum awareness. Software development has continued alongside these hardware initiatives, with work focused on model deployment, runtime capabilities and customer accessibility.

Conclusion

BrainChip's June-quarter update presents a company moving from technology development toward production, licensing and customer deployment, while continuing to invest in its broader product pipeline. At the same time, the revised AKD1500 production quantity, ongoing cash utilisation and the conclusion of the LDA financing arrangement remain important developments for investors monitoring the stock. The company's progress through the second half of 2026 will therefore centre on production deliveries, customer adoption, licensing activity and execution across its next-generation AI programs.